A new DRUG TRIALS SNAPSHOT FOR LARTRUVO is now available.
LARTRUVO is a drug used to treat a type of cancer called soft tissue sarcoma. It is to be used in adult patients together with another anti-cancer drug called doxorubicin when radiation or surgery is not possible.
Soft tissue sarcoma (STS) is a rare type of cancer that begins in the soft tissues of the body, such as muscles, tendons, fat, and blood vessels. There are more than 50 different types of STS.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.